MedDataX Logo

Effects of Renal Replacement Therapy With Hemoadsoption in Patients With Sepsis

NCT ID: NCT04533256

Last Updated: 2021-09-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-07-10

Study Completion Date

2021-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hemoadsorption has been demonstrated to improve clinical and paraclinical results in critically ill patients with sepsis and septic shock. The present study investigates the effects of three consecutive sessions of hemoadsorption, performed in accordance to the local protocol for treating patients with sepsis, on organ failure, severity scores and 30-days mortality. Paraclinical results and severity scores were obtained before and after the three consecutive sessions.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Adjuvant Therapy With CytoSorb in Refractory Septic Shock

NCT04013269

Septic Shock
UNKNOWN NA

Observational Trial on Cytokine Adsorption in Sepsis

NCT04306419

Sepsis Septic Shock Multiple Organ Failure
UNKNOWN

Cytokine Adsorption in Severe, Refractory Septic Shock

NCT04910893

Septic Shock Cytokine Storm
COMPLETED NA

Improvement of Cerebrovascular Autoregulation in Patients With Septic Shock Due to Cytokine Elimination

NCT04259567

Septic Shock
UNKNOWN NA

Therapeutic Plasma Exchange in Adult Patients With Severe Sepsis

NCT04057872

Septic Shock
COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sepsis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CytoSorb

three consecutive sessions of hemoadsorption in patients with sepsis

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients with sepsis or septic shock who require hemoadsorption in accordance with local guidelines

Exclusion Criteria

* unsigned informed consent
* duration of therapy under 12 hours
* death before the three consecutive sessions
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institutul Clinic Fundeni

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Popescu Mihai

clinical professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dana Tomescu, Prof

Role: STUDY_CHAIR

Fundeni Clinical Institute

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fundeni Clinical Institute

Bucharest, , Romania

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Romania

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Cyto-Sepsis

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effect of Sepsis Adsorption Column on Syndecan-1 and Mortality
NCT07033910 COMPLETED
The Benefits of Early Initiation of Continual Renal Replacement Therapy in Patients With Severe Sepsis
NCT03141112 UNKNOWN
Changes in Microvascular Perfusion During Blood Purification With Cytosorb® in Septic Shock
NCT03456180 COMPLETED
The Effect of Remote Ischemic Conditioning on the Microcirculation in Sepsis
NCT04644926 COMPLETED PHASE1/PHASE2
Citrate Versus Heparin Anticoagulation: Effect on Molecules Clearances
NCT01839578 UNKNOWN NA
Influence of Cytosorb on Amount of Catecholamine and Mortality in Sepsis
NCT04567199 COMPLETED
The Role of Blood Purification by Hemoadsorption as Adjunctive Treatment in Children With Septic Shock
NCT05401695 COMPLETED NA
Evaluating a CytoSorb Score in Septic Shock
NCT03977688 COMPLETED
Hemoperfusion in Critical Patients With Septic Multiorgan Dysfunction Syndrome.
NCT05044403 RECRUITING NA
Volemic Resuscitation in Sepsis and Septic Shock
NCT02565251 UNKNOWN NA
Data Analysis of the Cytokine Adsorption Treatment on Coronavirus Disease-19 (COVID-19) Patients With Respiratory Failure
NCT04422626 WITHDRAWN
Blood Purification in Septic Children
NCT05595239 NOT_YET_RECRUITING NA
CLinical Efficacy of Hemoperfusion With a Cytokine Adsorber in Norepinephrine-Resistant SEptic Shock
NCT05136183 UNKNOWN NA
Hemodynamic Impact of Cytosorb and CKRT in Children With Septic Shock
NCT05658588 COMPLETED NA
Efficacy of Melatonin in Patients With Severe Sepsis or Septic Shock
NCT01858909 UNKNOWN PHASE3
Cytokine Removal by CRRT in Pediatric Sepsis
NCT00537693 COMPLETED NA
Extracorporeal Cytokine Removal in Patients With Septic Shock in an Adult Intensive Care Unit
NCT04231695 UNKNOWN
Safety and Efficacy of Extracorporeal Cytokine Hemoadsorption in Septic Shock in Critically Ill Cirrhotics
NCT03866083 UNKNOWN NA
Cytokine Hemoadsorption in ECMO Patients
NCT04901338 COMPLETED
Statin for Immunomudulation in Sepsis
NCT00452608 UNKNOWN PHASE2
Cerebrovascular Autoregulation in Sepsis, Influence of Renal Replacement Therapy
NCT01926301 WITHDRAWN
Metabolic Cluster Analysis in Septic Shock Patients
NCT06500156 RECRUITING
Early Continuous Renal Replacement Therapies (CRRT) in Patients With Severe Sepsis or Septic Shock With Acute Kidney Injury
NCT00837057 UNKNOWN PHASE4
Use of Dobutamine in Patients With Sepsis and Maintained Hypoperfusion After Initial Volemic Resuscitation.
NCT05953142 NOT_YET_RECRUITING PHASE2
Safety and Efficiency of Combined Extracorporeal Blood Purification in Neurosurgical ICU. Prospective RCT
NCT04152174 UNKNOWN NA